METHOD FOR PREDICTING HEPATIC DEPRESSIVE SYNDROME IN FEMALE PATIENTS OF OBSTETRIC PROFILE

METHOD FOR PREDICTING HEPATIC DEPRESSIVE SYNDROME IN FEMALE PATIENTS OF OBSTETRIC PROFILE

medicine. SUBSTANCE: method involves applying hemostasis properties examination of pregnant women at the first trimester. Prognosis value S is determined as discriminant function on the basis of hemostasis indices of information contents like blood platelets, fibrinogen, activated partial thrombopla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ATAJANTS K.M, SEVAST'JANOVA O.JU, KOROLEVA S.V, JURCHENKO L.N, MAZUROV A.D
Format: Patent
Sprache:eng
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:medicine. SUBSTANCE: method involves applying hemostasis properties examination of pregnant women at the first trimester. Prognosis value S is determined as discriminant function on the basis of hemostasis indices of information contents like blood platelets, fibrinogen, activated partial thromboplastin time from a formula S = 0.024xD1 + 0.890xD2 - 0.071xD3 - 5.531, where D1 is the number of blood platelets in venous blood (x109/l), D2 is the fibrinogen level in blood serum (in g/l), D3 is the activated partial thromboplastin time (in s). S value being less than zero (S0), physiological adaptation of hepatocellular system to the pregnancy in progress is to be predicted. EFFECT: enhanced accuracy of prediction.